Palvella Therapeutics, Inc. Increase (Decrease) in Other Current Assets
Palvella Therapeutics, Inc. (PVLA) reported Increase (Decrease) in Other Current Assets of $768.90 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2015-08-13
- Palvella Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2015-06-30 was $451.83K.
- Palvella Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2015-03-31 was $317.07K, a 21.91% increase year-over-year.
- Palvella Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2014-06-30 was -$19.35K.
- Palvella Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2014-03-31 was $260.10K.
- Palvella Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2014 was $911.29K.
- Palvella Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2013 was -$691.68K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|
| 2015-06-30 | $451.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $768.90K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $317.07K 10-Q · filed 2015-05-14 | ||
| 2014-12-31 | $911.29K 10-K · filed 2015-03-30 | ||
| 2014-06-30 | -$19.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $240.74K 10-Q · filed 2015-08-13 | |
| 2014-03-31 | $260.10K 10-Q · filed 2015-05-14 | ||
| 2013-12-31 | -$691.68K 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |